Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Chiu

Showing results (221-230 of 328) with videos related to

Pageof 33
Sort By:
Bioinformatics (Oxford, England)|May 12, 2012
MicrobeDB: a locally maintainable database of microbial genomic sequencesMorgan G I Langille, Matthew R Laird, William W L Hsiao, et al.
Journal of Toxicology and Environmental Health. Part B, Critical Reviews|June 28, 2008
Approaches for applications of physiologically based pharmacokinetic models in risk assessmentChad M Thompson, Babasaheb Sonawane, Hugh A Barton, et al.
Analytical and Bioanalytical Chemistry|February 3, 2026
Maternal PFAS transfer through lactation: dolphin milk reveals routes of early-life exposureKara M Joseph, Ashlee T Falls, Sarah J Rehm, et al.
Chemical Research in Toxicology|July 24, 2024
Informing Hazard Identification and Risk Characterization of Environmental Chemicals by Combining Transcriptomic and Functional Data from Human-Induced Pluripotent Stem-Cell-Derived CardiomyocytesHan-Hsuan D Tsai, Lucie C Ford, Sarah D Burnett, et al.
Critical Reviews in Toxicology|May 12, 2006
Comments on article "Applying mode-of-action and pharmacokinetic considerations in contemporary cancer risk assessments: an example with trichloroethylene" by Clewell and AndersenJane C Caldwell, Marina V Evans, Allan H Marcus, et al.
Journal of Applied Toxicology : JAT|February 15, 2007
Evaluation of physiologically based pharmacokinetic models for use in risk assessmentWeihsueh A Chiu, Hugh A Barton, Robert S DeWoskin, et al.
Environment International|February 2, 2023
Characterizing vulnerabilities to climate change across the United StatesP Grace Tee Lewis, Weihsueh A Chiu, Ellu Nasser, et al.
Clinical Pharmacology and Therapeutics|October 23, 2018
Thorough QT/QTc in a Dish: An In Vitro Human Model That Accurately Predicts Clinical Concentration-QTc RelationshipsAlexander D Blanchette, Fabian A Grimm, Chimeddulam Dalaijamts, et al.
Toxics|August 25, 2022
A Population-Based Human In Vitro Approach to Quantify Inter-Individual Variability in Responses to Chemical MixturesLucie C Ford, Suji Jang, Zunwei Chen, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 23, 2021
A Bayesian population physiologically based pharmacokinetic absorption modeling approach to support generic drug development: application to bupropion hydrochloride oral dosage formsNan-Hung Hsieh, Frédéric Y Bois, Eleftheria Tsakalozou, et al.
Pageof 33

Showing results (221-230 of 328) with videos related to

Sort By:
Pageof 33
Bioinformatics (Oxford, England)|May 12, 2012
MicrobeDB: a locally maintainable database of microbial genomic sequencesMorgan G I Langille, Matthew R Laird, William W L Hsiao, et al.
Journal of Toxicology and Environmental Health. Part B, Critical Reviews|June 28, 2008
Approaches for applications of physiologically based pharmacokinetic models in risk assessmentChad M Thompson, Babasaheb Sonawane, Hugh A Barton, et al.
Analytical and Bioanalytical Chemistry|February 3, 2026
Maternal PFAS transfer through lactation: dolphin milk reveals routes of early-life exposureKara M Joseph, Ashlee T Falls, Sarah J Rehm, et al.
Chemical Research in Toxicology|July 24, 2024
Informing Hazard Identification and Risk Characterization of Environmental Chemicals by Combining Transcriptomic and Functional Data from Human-Induced Pluripotent Stem-Cell-Derived CardiomyocytesHan-Hsuan D Tsai, Lucie C Ford, Sarah D Burnett, et al.
Critical Reviews in Toxicology|May 12, 2006
Comments on article "Applying mode-of-action and pharmacokinetic considerations in contemporary cancer risk assessments: an example with trichloroethylene" by Clewell and AndersenJane C Caldwell, Marina V Evans, Allan H Marcus, et al.
Journal of Applied Toxicology : JAT|February 15, 2007
Evaluation of physiologically based pharmacokinetic models for use in risk assessmentWeihsueh A Chiu, Hugh A Barton, Robert S DeWoskin, et al.
Environment International|February 2, 2023
Characterizing vulnerabilities to climate change across the United StatesP Grace Tee Lewis, Weihsueh A Chiu, Ellu Nasser, et al.
Clinical Pharmacology and Therapeutics|October 23, 2018
Thorough QT/QTc in a Dish: An In Vitro Human Model That Accurately Predicts Clinical Concentration-QTc RelationshipsAlexander D Blanchette, Fabian A Grimm, Chimeddulam Dalaijamts, et al.
Toxics|August 25, 2022
A Population-Based Human In Vitro Approach to Quantify Inter-Individual Variability in Responses to Chemical MixturesLucie C Ford, Suji Jang, Zunwei Chen, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 23, 2021
A Bayesian population physiologically based pharmacokinetic absorption modeling approach to support generic drug development: application to bupropion hydrochloride oral dosage formsNan-Hung Hsieh, Frédéric Y Bois, Eleftheria Tsakalozou, et al.
Pageof 33